EWTX - Edgewise Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EWTX is currently covered by 6 analysts with an average price target of $33.95. This is a potential upside of $19.16 (129.55%) from yesterday's end of day stock price of $14.79.

Edgewise Therapeutics's activity chart (see below) currently has 20 price targets and 44 ratings on display. The stock rating distribution of EWTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.38% with an average time for these price targets to be met of 322.14 days.

Highest price target for EWTX is $51, Lowest price target is $31, average price target is $45.

Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 21-Apr-2025. First documented stock forecast 19-Apr-2021.

Currently out of the existing stock ratings of EWTX, 29 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$43

$28.22 (190.93%)

$45

28 days ago
(21-Apr-2025)

6/10 (60%)

$29.7 (223.31%)

297

Buy

$51

$36.22 (245.06%)

$51

1 months 17 days ago
(02-Apr-2025)

0/4 (0%)

$35.48 (228.61%)

Buy

$50

$35.22 (238.29%)

$45

5 months 2 days ago
(17-Dec-2024)

0/2 (0%)

$19.83 (65.73%)

Buy

$50

$35.22 (238.29%)

$33

5 months 22 days ago
(27-Nov-2024)

3/4 (75%)

$17.8 (55.28%)

211

Buy

$31

$16.22 (109.74%)

$30

9 months 7 days ago
(12-Aug-2024)

10/10 (100%)

$13.95 (81.82%)

631

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EWTX (Edgewise Therapeutics) average time for price targets to be met?

On average it took 322.14 days on average for the stock forecasts to be realized with a an average price target met ratio 57.38

Which analyst has the current highest performing score on EWTX (Edgewise Therapeutics) with a proven track record?

LAURA CHICO

Which analyst has the current lower performing score on EWTX (Edgewise Therapeutics) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on EWTX (Edgewise Therapeutics)?

Laura Chico works at WEDBUSH and has 22 price targets and 12 ratings on EWTX

Which analyst is the currently most bullish on EWTX (Edgewise Therapeutics)?

Yasmeen Rahimi with highest potential upside - $36.22

Which analyst is the currently most reserved on EWTX (Edgewise Therapeutics)?

Madhu Kumar with lowest potential downside - -$9.78

Edgewise Therapeutics in the News

Edgewise Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

– Announced positive top-line results from Phase 2 CIRRUS-HCM trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) – – Strengthened balance sheet with net proceeds of approximately $188 million from the April 2025 public offering; pro-forma cash balance exceeds $624 million – –  On track to report data from the Phase 2 LYNX and FOX trials of...

Edgewise Therapeutics, Inc. (EWTX): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout

We recently published a list of 20 Stocks Insiders Bought in April After Trump’s Tariff Rollout. In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other stocks that insiders bought in April after Trump’s tariff rollout. President Donald Trump called April 2 a “Liberation Day” after...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?